• Researchers develop an Ebola vaccine

    Researchers develop an experimental vaccine that cures the Ebola virus by targeting its genetic material; trouble is, the Ebola vaccine can only work if it is administered within thirty minutes, which is an impracticality among civilian populations; the vaccine is a viable possibility within a research facility, so it may be used to protect the researchers themselves

  • Coral snake antivenin to run out in October

    If you live in Florida, you should now be doubly careful not to be bitten by the poisonous coral snake; the only company making antivenin for coral snake bites is no longer producing the drug — and the last batch will hit its expiration date in October.

  • Defeating anthrax bacterium's natural defenses may hold key to new treatments

    Up to 90 percent of untreated cases of inhalational anthrax result in death; Bacillus anthracis, the causative agent of anthrax, is particularly lethal because of its protective coating, or capsule, which enables the pathogen to escape destruction by the host’s immune system; researchers discover a way to “trick” the bacterium into shedding its protective covering

  • Utah implements harsh triage guidelines for bioterror, epidemic emergencies

    Utah’s new triage health emergency guidelines would see some children and some seniors turned away from hospitals during a bioterror or epidemic emergency; those who are severely burned, have incurable and spreading cancer, fatal genetic diseases, end-stage multiple sclerosis, or severe dementia will be turned away; people older than 85 also would not be admitted in the worst pandemic; those who have signed “do not resuscitate” orders could be denied a bed

    • view counter

  • Is there a connection between ending smallpox vaccination and the explosive spread of HIV?

    Smallpox immunization was gradually withdrawn from the 1950s to the 1970s following the worldwide eradication of the disease, and HIV has been spreading exponentially since approximately the same time; researchers show that vaccinia immunization, given to prevent the spread of smallpox, produces a five-fold reduction in HIV replication in the laboratory; is there a connection between the end of smallpox immunization and the spread of HIV?

  • Ricin: the most potent -- and readily available -- bioterrorism weapon

    Ricin is of particular concern when it comes to bioterror agents: ricin is not only deadly, but it is also easy to obtain; it is a natural ingredient in the seeds of castor oil plants, which are used in the industrial production of brake fluid, varnish, soap, ink and other products; researchers offer ways to protect human cells from ricin

    • view counter

  • Synthesized polymer neutralizes both biological and chemical weapons

    Biological tissues to respond rapidly and appropriately to changing environments; this logic was applied by University of Pittsburgh researchers: they have synthesized a single, multifunctional polymer material that can decontaminate both biological and chemical toxins

  • Korean scientists develop fast, accurate pathogen detection sensor

    On average 540 million people become sick with harmful bacteria every year with fifteen million losing their lives to infectious disease around the world; the key to fighting infectious disease is for doctors to determine quickly what kind of pathogen or infectious agents have entered the body and sidestepped the natural immune system

  • Beating mosquitoes at their own game

    Japanese researchers came up with a brilliant idea: why not use mosquitoes as “flying vaccinators” or “flying syringes”? Normally, when mosquitoes bite, they inject a tiny drop of saliva that prevents the host’s blood from clotting; the Japanese group decided to add an antigen — a compound that triggers an immune response — to the mix of proteins in the insect’s saliva; it worked

  • Nuclear Medical Center established for early detection of injuries

    The Israeli military uses a new technology which allows early detection of injuries sustained by soldiers better than any other diagnostic tests; the system uses a new nuclear medicine system, which includes a new nuclear camera; the new camera has a sensitivity of 100 percent for diagnosing stress fractures, enabling the diagnosis of an injury already at the stage of a minor fracture and prevents it from worsening

  • iPhone app saves lives

    A new iPhone app guides users as to what to do when resuscitating critically ill patients in cardiac arrest or near cardiac arrest; depending on the age and condition of the patient, the user follows certain prompts to remind them of what to do

  • How best to protect first responders from anthrax

    The first responders who rushed to Senator Tom Daschle’s office on 15 October 2001 were protected by personal protective equipment (PPE); yet, nasal swabs taken from them after they got out of the building revealed that some had been exposed to anthrax; experts argue that first responders and emergency personnel should all be vaccinated

  • Two New York labs to develop anti-botulism drugs

    U.S. Department of Energy’s Brookhaven National Laboratory and Stony Brook University’s Institute of Chemical Biology and Drug Discovery to receive $1.4 million in Department of Defense research funds to develop anti-botulism drugs

  • New ways found to tackle deadly South American hemorrhagic fever viruses

    New World hemorrhagic fevers are nasty, serious, and often fatal diseases which cause Ebola-like symptoms; most outbreaks occur in rural regions of Bolivia, Venezuela, Argentina, and Brazil; the outbreaks of New World hemorrhagic fever tend to be brief and brutal, with mortality rates of 20 to 30 percent; scientists have discovered exactly how one type of New World hemorrhagic fever virus latches onto and infects human cells, offering a much-needed lead toward new treatments

  • iBio to license vaccine production facility using green plant technology

    iBio will license the iBioLaunch platform to G-Con, LLC, a private Texas company; the “GreenVax Project” uses Nicotiana plants grown hydroponically; the green plant technology platform holds the promise of shortening vaccine production from months to weeks